Drug-lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

Advanced Drug Delivery Reviews

Volumn 64, Issue 3, 2012, Pages 275-284

  Zhou, Qi Tony ^a   Morton, David A V ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesive mixture; Aerosol performance; Cohesive adhesive balance; Dry powder inhaler; Force control agents; Lactose carrier; Mechanical dry powder coating; Surface coating characterization; Surface modification

Indexed keywords

DRY POWDER COATINGS; DRY POWDER INHALER; FORCE CONTROL AGENTS; LACTOSE CARRIER; SURFACE COATING CHARACTERIZATION;

ATMOSPHERIC AEROSOLS; POWDER COATINGS; SURFACE TREATMENT;

SUGARS;

BECLOMETASONE DIPROPIONATE; CARBOMER; DRUG ADDITIVE; DRUG CARRIER; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE; SALBUTAMOL; SOLVENT;

AEROSOL; ATOMIC FORCE MICROSCOPY; BINDING KINETICS; CHEMICAL MODIFICATION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; FLOW KINETICS; MATERIAL COATING; METHODOLOGY; POWDER INHALER; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TIME OF FLIGHT MASS SPECTROMETRY; X RAY PHOTOELECTRON SPECTROSCOPY;

ADHESIVES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRY POWDER INHALERS; LACTOSE; PHARMACEUTICAL PREPARATIONS; SURFACE PROPERTIES;

EID: 84858618162     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.07.002     Document Type: Review

References (90)

1. Begat P., Morton D.A.V., Staniforth J.N., Price R. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics. Pharmaceutical Research 2004, 21:1826-1833.
2. Chan H.K., Chew N.Y.K. Novel alternative methods for the delivery of drugs for the treatment of asthma. Advanced Drug Delivery Reviews 2003, 55:793-805.
3. Prime D., Atkins P.J., Slater A., Sumby B. Review of dry powder inhalers. Advanced Drug Delivery Reviews 1997, 26:51-58.
4. Jones M.D., Price R. The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharmaceutical Research 2006, 23:1665-1674.
5. Stewart P.J., Adi H., Larson I. Dry powder inhaler formulations-simple two component powder mixtures or a multi-particulate nightmare. Drug Delivery to the Lungs 16 2005, 81-84. Edinburgh, UK.
6. Tobyn M., Staniforth J.N., Morton D., Harmer Q., Newton M.E. Active and intelligent inhaler device development. International Journal of Pharmaceutics 2004, 277:31-37.
7. Morton D.A.V., Staniforth J.N. The challenge of the new: device-formulation matching in dry powder inhaler systems, pharmaceutical manufacturing and packing sourcer. Spring 2005, 80-83.
8. Telko M.J., Hickey A.J. Dry powder inhaler formulation. Respiratory Care 2005, 50:1209-1227.
9. Weers J.G., Tarara T.E., Clark A.R. Design of fine particles for pulmonary drug delivery. Expert Opinion on Drug Delivery 2007, 4:297-313.
10. Palakodaty S., York P., Pritchard J. Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance. Pharmaceutical Research 1998, 15:1835-1843.
11. Rehman M., Shekunov B.Y., York P., Lechuga-Ballesteros D., Miller D.P., Tan T., Colthorpe P. Optimisation of powders for pulmonary delivery using supercritical fluid technology. European Journal of Pharmaceutical Sciences 2004, 22:1-17.
12. Heng P.W.S., Chan L.W., Lim L.T. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate. Chemical and Pharmaceutical Bulletin 2000, 48:393-398.
13. Chan L.W., Lim L.T., Heng P.W.S. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations. Journal of Pharmaceutical Sciences 2003, 92:975-984.
14. Edwards D.A., Hanes J., Caponetti G., Hrkach J., BenJebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science 1997, 276:1868-1871.
15. Young P.A., Edge S., Traini D., Jones M.D., Price R., El-Sabawi D., Urry C., Smith C. The influence of dose on the performance of dry powder inhalation systems. International Journal of Pharmaceutics 2005, 296:26-33.
16. Reuzel P.G.J., Bruijntjes J.P., Feron V.J., Woutersen R.A. Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food and Chemical Toxicology 1991, 29:341-354.
17. Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate. European Journal of Pharmaceutics and Biopharmaceutics 2001, 51:55-62.
18. Zeng X.M., Martin G.P., Marriott C., Pritchard J. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates. The Journal of Pharmacy and Pharmacology 2000, 52:1211-1221.
19. Iida K., Hayakawa Y., Okamoto H., Danjo K., Leuenberger H. Preparation of dry powder inhalation by surface treatment of lactose carrier particles. Chemical and Pharmaceutical Bulletin 2003, 51:1-5.
20. Iida K., Todo H., Okamoto H., Danjo K., Leuenberger H. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed. Chemical and Pharmaceutical Bulletin 2005, 53:431-434.
21. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. International Journal of Pharmaceutics 1998, 172:179-188.
22. Yuasa H., Nakano T., Kanaya Y. Suppression of agglomeration in fluidized bed coating - I. Suppression of agglomeration by adding NaCl. International Journal of Pharmaceutics 1997, 158:195-201.
23. G. Caponetti, P.L. Catellani, R. Bettini, P. Colombo, P. Ventura, Powders consisting of particles with a perfectly smooth surface for use as carriers for the preparation of inhalation mixtures with micronized drugs and method for their preparation. International patent, PCT/EP/06690., in, 2002.
24. Young P.M., Cocconi D., Colombo P., Bettini R., Price R., Steele D.F., Tobyn M.J. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". The Journal of Pharmacy and Pharmacology 2002, 54:1339-1344.
25. Bettini R. Smoothed lactose carriers. Lactose as a Carrier for Inhalation Products Conference 2010, 41-42. Parma, Italy.
26. P. Chiesi, L. Pavesi, P. Via, New pharmaceutical compositions for inhalation. International patent, PCT/EP87/00118., in, 1987.
27. R. Musa, P. Ventura, P. Chiesi, Improved powdery pharmaceutical compositions for inhalation. International patent, PCT/EP99/01449, in, 2000.
28. M. Keller, R. Müller-Walz, Dry powder for inhalation, in: US patent 7,186,401 B2, 2007.
29. J. Staniforth, Carrier particles for use in dry powder inhalers. International patent, PCT/GB96/00215., in, 1996.
30. Miller T.A., York P. Pharmaceutical tablet lubrication. International Journal of Pharmaceutics 1988, 41:1-19.
31. Zhou Q., Armstrong B., Larson I., Stewart P.J., Morton D.A.V. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating. Journal of Pharmaceutical Sciences 2010, 99:969-981.
32. J.N. Staniforth, D.A.V. Morton, Particle for use in pharmaceutical composition. International patent, PCT/GB01/05305., in, 2001.
33. Begat P., Price R., Harris H., Morton D.A.V., Staniforth J.N. The Influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations. KONA 2005, 23:109-121.
34. Kumon M., Suzuki M., Kusai A., Yonemochi E., Terada K. Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC. Chemical and Pharmaceutical Bulletin 2006, 54:1508-1514.
35. Pfeffer R., Dave R.N., Wei D., Ramlakhan M. Synthesis of engineered particulates with tailored properties using dry particle coating. Powder Technology 2001, 117:40-67.
36. Naito M., Kondo A., Yokoyama T. Applications of comminution techniques for the surface modification of powder materials. ISIJ International 1993, 33:915-924.
37. Gera M., Saharan V.A., Kataria M., Kukkar V. Mechanical methods for dry particle coating processes and their applications in drug delivery and development. Recent Patents on Drug Delivery & Formulation 2010, 4:58-81.
38. D. Morton, Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives. International patent application, PCT/GB2005/050211., in, 2008.
39. Zhou Q.T., Armstrong B., Larson I., Stewart P.J., Morton D.A.V. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders. European Journal of Pharmaceutical Sciences 2010, 40:412-421.
40. Zhou Q.T., Qu L., Larson I., Stewart P.J., Morton D.A.V. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach. International Journal of Pharmaceutics 2010, 394:50-59.
41. Begat P., Morton D.A.V., Shur J., Kippax P., Staniforth J.N., Price R. The role of force control agents in high-dose dry powder inhaler formulations. Journal of Pharmaceutical Sciences 2009, 98:2770-2783.
42. Kumon M., Machida S., Suzuki M., Kusai A., Yonemochi E., Terada K. Application and mechanism of inhalation profile improvement of DPI formulations by mechanofusion with magnesium stearate. Chemical and Pharmaceutical Bulletin 2008, 56:617-625.
43. Tijburg I., Jagiello J., Vidal A., Papirer E. Inverse gas-chromatographic studies on silica - infinite dilution and finite concentration measurements. Langmuir 1991, 7:2243-2247.
44. Yla-Maihaniemi P.P., Heng J.Y.Y., Thielmann F., Williams D.R. Inverse gas chromatographic method for measuring the dispersive surface energy distribution for particulates. Langmuir 2008, 24:9551-9557.
45. Tay T., Das S., Stewart P. Magnesium stearate increases salbutamol sulphate dispersion: What is the mechanism?. International Journal of Pharmaceutics 2010, 383:62-69.
46. S.C. Das, Q. Zhou, D.A.V. Morton, I. Larson, P.J. Stewart. Use of surface energy distributions by inverse gas chromatography to understand mechanofusion processing and functionality of lactose coated with magnesium stearate. European Journal of Pharmaceutical Sciences 43 (2011) (4) 325-333.
47. Q. Zhou, B. Armstrong, I. Larson, P.J. Stewart, D.A.V. Morton, Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating, Journal of Pharmaceutical Sciences 99 (2010) (2) 969-981.
48. Zhou Q.T., Qu L., Larson I., Stewart P.J., Morton D.A.V. Effect of mechanical dry particle coating on the improvement of powder flowability for lactose monohydrate: a model cohesive pharmaceutical powder. Powder Technology 2011, 207:414-421.
49. Green M., Vale K., Perkins M., Whiteside P. Surface coating of lactose and API particles with magnesium stearate. Respiratory Drug Delivery Europe 2009 2009, 445-448. Davis Healthcare International Publishing LLC. D. RN (Ed.).
50. Zhou Q.T., Denman J.A., Gengenbach T., Das S., Qu L., Zhang H., Larson I., Stewart P.J., Morton D.A.V. Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach. Journal of Pharmaceutical Sciences 2011, 100:3421-3430.
51. Zhou Q.T., Qu L., Gengenbach T., Denman J.A., Larson I., Stewart P.J., Morton D.A.V. Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties. International Journal of Pharmaceutics 2011, 413:36-43.
52. Iida K., Hayakawa Y., Okamoto H., Danjo K., Luenberger H. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chemical and Pharmaceutical Bulletin 2003, 51:1455-1457.
53. Iida K., Inagaki Y., Todo H., Okamoto H., Danjo K., Luenberger H. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chemical and Pharmaceutical Bulletin 2004, 52:938-942.
54. Iida K., Hayakawa Y., Okamoto H., Danjo K., Luenberger H. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier. Chemical and Pharmaceutical Bulletin 2004, 52:444-446.
55. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H. Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200). International Journal of Pharmaceutics 1998, 173:243-251.
56. Honda H., Kimura M., Honda F., Matsuno T., Koishi M. Preparation of monolayer particle coated powder by the dry impact blending process utilizing mechanochemical treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects 1994, 82:117-128.
57. Thomas G., Ouabbas Y., Grosseau P., Baron M., Chamayou A., Galet L. Modeling the mean interaction forces between powder particles. Application to silica gel-magnesium stearate mixtures, Applied Surface Science 2009, 255:7500-7507.
58. Yang J., Sliva A., Banerjee A., Dave R.N., Pfeffer R. Dry particle coating for improving the flowability of cohesive powders. Powder Technology 2005, 158:21-33.
59. Mujumdar A., Wei D., Dave R.N., Pfeffer R., Wu C.Y. Improvement of humidity resistance of magnesium powder using dry particle coating. Powder Technology 2004, 140:86-97.
60. Spillmann A., Sonnenfeld A., von Rohr P.R. Effect of surface free energy on the flowability of lactose powder treated by PECVD. Plasma Processes and Polymers 2008, 5:753-758.
61. D. Ganderton, D.A.V. Morton, P. Lucas, Powders. US patent, US6989155B1, in, 2006.
62. J. Raula, F. Thielmann, M. Naderi, V.P. Lehto, E.I. Kauppinen, Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders, Int. J. Pharm., 385 79-85.
63. Hussain M.S.H., York P., Timmins P. a study of the formation of magnesium stearate film on sodium-chloride using energy-dispersive X-ray-analysis. International Journal of Pharmaceutics 1988, 42:89-95.
64. Pintyehodi K., Toth I., Kata M. Investigation of the formation of magnesium stearate film by energy dispersive-X-ray microanalysis. Pharmaceutica Acta Helvetiae 1981, 56:320-324.
65. Al-Shatti L.A., Marafie H.M., Shoukry A.F. Surface analysis of new chlorpromazinium plastic membrane electrodes. Journal of Pharmaceutical and Biomedical Analysis 2008, 46:328-334.
66. Widjaja E., Seah R.K.H. Application of Raman microscopy and band-target entropy minimization to identify minor components in model pharmaceutical tablets. Journal of Pharmaceutical and Biomedical Analysis 2008, 46:274-281.
67. McGoverin C.M., Rades T., Gordon K.C. Recent pharmaceutical applications of Raman and terahertz spectroscopies. Journal of Pharmaceutical Sciences 2008, 97:4598-4621.
68. Belu A.M., Davies M.C., Newton J.M., Patel N. TOF-SIMS characterization and imaging of controlled-release drug delivery systems. Analytical Chemistry 2000, 72:5625-5638.
69. Adriaens A., Van Vaeck L., Adams F. Static secondary ion mass spectrometry (S-SIMS) Part 2: material science applications. Mass Spectrometry Reviews 1999, 18:48-81.
70. Van Vaeck L., Adriaens A., Gijbels R. Static secondary ion mass spectrometry: (S-SIMS) Part 1. Methodology and structural interpretation. Mass Spectrometry Reviews 1999, 18:1-47.
71. Chesko J., Kazzaz J., Ugozzoli M., Singh M., O'Hagan D.T., Madden C., Perkins M., Patel N. Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS. Journal of Pharmaceutical Sciences 2008, 97:1443-1453.
72. Fulghum J.E., Linton R.W. Quantitation of coverages on rough surfaces by XPS - an overview. Surfaces in Interface Analysis 1988, 13:186-192.
73. Davies M.C., Wilding I.R., Short R.D., Khan M.A., Watts J.F., Melia C.D. An analysis of the surface chemical-structure of polymethacrylate (Eudragit) film coating polymers by XPS. International Journal of Pharmaceutics 1989, 57:183-187.
74. Lamb R.N., Baxter J., Grunze M., Kong C.W., Unertl W.N. An XPS study of the composition of thin polyimide films formed by vapor-Deposition. Langmuir 1988, 4:249-256.
75. Liu Z., Wu X.Y., Ballinger J.R., Bendayan R. Synthesis and characterization of surface-hydrophobic ion-exchange microspheres and the effect of coating on drug release rate. Journal of Pharmaceutical Sciences 2000, 89:807-817.
76. Viornery C., Chevolot Y., Leonard D., Aronsson B.O., Pechy P., Mathieu H.J., Descouts P., Gratzel M. Surface modification of titanium with phosphonic acid to improve bone bonding: characterization by XPS and ToF-SIMS. Langmuir 2002, 18:2582-2589.
77. Zhou Q., Qu L., Denman J., Gengenbach T., Stewart P.J., Morton D.A.V. Understanding the influence of surface modification via mechanical dry coating on the flowability of a cohesive fine lactose powder. Drug Delivery to Lungs 21 2010, Edinburg, UK.
78. Zhou Q., Qu L., Denman J., Gengenbach T., Stewart P.J., Morton D.A.V. Investigating the effect of nano-scale surface coating on the aerosolization of micronized drug powders. Drug Delivery to Lungs 21 2010, Edinburg, UK.
79. Shur J., Harris H., Jones M.D., Kaerger J.S., Price R. The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharmaceutical Research 2008, 25:1631-1640.
80. Kippax P., Morton D.A.V. Aerosolization analysis. Drug Delivery Technology 2008, 8:53-58.
81. Chan H.K. Inhalation drug delivery devices and emerging technologies. Expert Opinion on Therapeutic Patents 2003, 13:1333-1343.
82. Islam N., Gladki E. Dry powder inhalers (DPIs)-a review of device reliability and innovation. International Journal of Pharmaceutics 2008, 360:1-11.
83. Mitchell J.P., Nagel M.W. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2003, 16:341-377.
84. Clark A., Kadrichu N. Comparing pharmaceutical aerosol particle size distributions. Respiratory Drug Delivery VII 2000, 181-190. Serentec Press, Tarpon Springs, Florida.
85. Das S., Larson I., Young P., Stewart P. Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation. Journal of Pharmaceutical Sciences 2009, 98:1015-1027.
86. Zhu K., Tan R.B.H., Kiong Ng W., Shen S., Zhou Q., Heng P.W.S. Analysis of the influence of relative humidity on the moisture sorption of particles and the aerosolization process in a dry powder inhaler. Journal of Aerosol Science 2008, 39:510-524.
87. Young P.M., Sung A., Traini D., Kwok P., Chiou H., Chan H.K. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Pharmaceutical Research 2007, 24:963-970.
88. Harjunen P., Lankinen T., Salonen H., Lehto V.P., Järvinen K. Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI. International Journal of Pharmaceutics 2003, 263:151-163.
89. Price R., Young P.M., Edge S., Staniforth J.N. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations. International Journal of Pharmaceutics 2002, 246:47-59.
90. M. Thomas, Pharmaceutical formulations, in: WIPO Patent Application WO/2005/004852, 2005.